Xuchang KETOP Testing Research Institute Co.,Ltd (SHE:003008)
China · Delayed Price · Currency is CNY 19.80
+0.04 (0.20%)
Oct 9, 2026, 3:04 PM CST
SHE:003008 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 216.45 | 231.51 | 220.1 | 189.62 | 154.93 | 142.79 |
Other Revenue | 1.17 | 1.22 | 1.24 | 1.21 | 1.05 | 1.11 |
| 217.62 | 232.73 | 221.34 | 190.83 | 155.98 | 143.9 | |
Revenue Growth | -3.20% | 5.15% | 15.99% | 22.34% | 8.40% | -13.05% |
Cost of Revenue | 76.99 | 76.23 | 74.41 | 65.51 | 47.87 | 46.03 |
Gross Profit | 140.63 | 156.5 | 146.93 | 125.32 | 108.11 | 97.87 |
Selling, General & Admin | 43.09 | 44.97 | 44.43 | 45.19 | 31.79 | 27.86 |
Research & Development | 12.68 | 12.96 | 11.2 | 11.78 | 10.6 | 10.02 |
Other Operating Expenses | 5.44 | 5.16 | 5.04 | 4.74 | 2.55 | 2.44 |
Operating Expenses | 61.81 | 63.99 | 60.76 | 62.48 | 45.09 | 40.37 |
Operating Income | 78.82 | 92.51 | 86.17 | 62.83 | 63.02 | 57.49 |
Interest Expense | -0.01 | -0.02 | -0.03 | -0.03 | -0.04 | -0.02 |
Interest & Investment Income | 14.99 | 13.04 | 16.94 | 14.84 | 17.13 | 15.46 |
Currency Exchange Gain (Loss) | 0 | -0 | -0.01 | -0 | -0.01 | - |
Other Non Operating Income (Expenses) | -0.08 | -0.03 | -0.02 | -0.02 | -0.01 | -0.02 |
EBT Excluding Unusual Items | 93.71 | 105.5 | 103.05 | 77.62 | 80.09 | 72.92 |
Gain (Loss) on Sale of Investments | 0.01 | -0.32 | -0.46 | 0.3 | -0.43 | 0.4 |
Gain (Loss) on Sale of Assets | - | - | - | - | 0 | - |
Asset Writedown | -0.21 | -2.32 | -0.37 | -0.11 | -0.03 | -0.25 |
Other Unusual Items | 0.96 | 0.69 | 1.17 | 6.86 | 1.39 | 2.18 |
Pretax Income | 94.48 | 103.54 | 103.39 | 84.66 | 81.03 | 75.25 |
Income Tax Expense | 14.35 | 15.35 | 17.84 | 25.87 | 12.02 | 11 |
Net Income | 80.13 | 88.19 | 85.56 | 58.79 | 69.01 | 64.25 |
Net Income to Common | 80.13 | 88.19 | 85.56 | 58.79 | 69.01 | 64.25 |
Net Income Growth | -7.93% | 3.08% | 45.52% | -14.81% | 7.40% | -13.48% |
Shares Outstanding (Basic) | 104 | 104 | 104 | 103 | 104 | 104 |
Shares Outstanding (Diluted) | 104 | 104 | 104 | 103 | 104 | 104 |
Shares Change | -0.62% | -0.56% | 1.16% | -1.13% | -0.08% | 23.29% |
EPS (Basic) | 0.77 | 0.85 | 0.82 | 0.57 | 0.66 | 0.62 |
EPS (Diluted) | 0.77 | 0.85 | 0.82 | 0.57 | 0.66 | 0.62 |
EPS Growth | -7.35% | 3.66% | 43.86% | -13.83% | 7.49% | -29.82% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Free Cash Flow | 91.28 | 93.79 | 70.01 | 59.42 | 10.13 | 2.22 |
Free Cash Flow Per Share | 0.88 | 0.90 | 0.67 | 0.58 | 0.10 | 0.02 |
Dividend Per Share | 1.000 | 1.000 | 1.000 | 0.231 | 0.385 | 0.385 |
Dividend Growth | 5.26% | 0% | 333.28% | -39.99% | 0% | -16.66% |
Gross Margin | 64.62% | 67.24% | 66.38% | 65.67% | 69.31% | 68.01% |
Operating Margin | 36.22% | 39.75% | 38.93% | 32.93% | 40.40% | 39.95% |
Profit Margin | 36.82% | 37.90% | 38.65% | 30.81% | 44.24% | 44.65% |
Free Cash Flow Margin | 41.95% | 40.30% | 31.63% | 31.14% | 6.49% | 1.54% |
EBITDA | 132.87 | 146.34 | 139.29 | 118.59 | 101.06 | 89.56 |
EBITDA Margin | 61.06% | 62.88% | 62.93% | 62.14% | 64.79% | 62.24% |
D&A For EBITDA | 54.05 | 53.83 | 53.12 | 55.75 | 38.04 | 32.06 |
EBIT | 78.82 | 92.51 | 86.17 | 62.83 | 63.02 | 57.49 |
EBIT Margin | 36.22% | 39.75% | 38.93% | 32.93% | 40.40% | 39.95% |
Effective Tax Rate | 15.19% | 14.82% | 17.25% | 30.56% | 14.83% | 14.61% |
Revenue as Reported | 217.62 | 232.73 | 221.34 | 190.83 | 155.98 | 143.9 |